Status
Conditions
Treatments
About
To allow the use of domperidone by patients with gastrointestinal disorders who have failed standard therapy.
Full description
To provide oral domperidone to patients ≥12 years of age where, according to the investigator's judgment, a prokinetic effect is needed for the relief of refractory gastroesophageal reflux disease with upper gastrointestinal (GI) symptoms, gastroparesis, and chronic constipation in patients whom the potential benefit may outweigh the risk of cardiovascular adverse reactions including QT prolongation, Torsades de Pointes, and death.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
History of, or current, arrhythmias including ventricular tachycardia, ventricular fibrillation and Torsades de Pointes. Patients with minor forms of ectopy (PACs) are not necessarily excluded.
Loading...
Central trial contact
Devin Spaulding, BS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal